Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: XL147 (SAR245408)|DRUG: XL765 (SAR245409)|DRUG: letrozole (Femara)
Sponsor: Sanofi